Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Basic tumor immunology

Original research

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

	Abstract	Full	Pdf
Jun 2022	644	669	244
Jul 2022	376	386	122
Aug 2022	191	196	54
Sep 2022	172	175	65
Oct 2022	177	180	64
Nov 2022	136	137	56
Dec 2022	125	125	35
Jan 2023	99	100	32
Feb 2023	88	91	45
Mar 2023	81	83	43
Apr 2023	43	44	17
May 2023	65	66	33
Jun 2023	48	48	13
Jul 2023	48	48	21
Aug 2023	37	36	23
Sep 2023	43	43	19
Oct 2023	51	53	21
Nov 2023	87	87	36
Dec 2023	72	73	41
Jan 2024	53	54	27
Feb 2024	58	58	46
Mar 2024	68	68	98
Total	2762	2820	1155